medigraphic.com
ISSN 0210-5187 (Digital)

2005, Número 5

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2005; 33 (5)


Beneficios da isotretinoína no tratamento da acne nódulo-cística em pacientes hiperandrogênicas devido à síndrome dos ovários policísticos

Carvalho LA, Carvalho LA

Idioma: Portugués
Referencias bibliográficas: 20
Paginas: 211-218
Archivo PDF: 179.28 Kb.


RESUMEN

Sin Resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in Adolescent Girls with Polycystic Ovary Syndrome. Arch Pediatr Adolesc Med. 2002;156:556 - 60.

  2. Lobo R, Carmina E, The Importance of Diagnosing the Polycystic Ovary Syndrome. Ann Intern Med. 2000;132:989-93.

  3. Taylor AE, Insulin-Lowering Medications in Polycystic Ovary Syndrome. Obstet Gynecol Clin, 2000;27:583-95.

  4. Baillargeon JP, Iuorno MJ, Nestler JE, et al. Insulin Sensitizers for Polycystic Ovary Syndrome. Clin Obstet Gynaecol, 2003;46: 325-40.

  5. Meirelles RMR. Desvendando os Mistérios da Mulher (pelo Menos os Endócrinos) Arq Bras Endocrinol Metab, 2001;45:317-9.

  6. Tartagni M, Schonauer LM, De Salvia MA, et al. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril, 2000;73:718-23.

  7. Shaw JC. Hormonal therapy in Dermatology. Dermatol Clin, 2001;19:169-78. 8. Meisler JG. Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women. J Women Health, 2003;12:533-9.

  8. Bershad SV. The Modern Age of Acne Therapy: A Review of Current Treatment Options. Mount Sinai J Medicine, 2001;68: 279-86.

  9. Faure M. Acné et hormones. Rev Prat, 2002;52:850 -3.

  10. Tan JKL, Vasey K, Fung KY. Attitudes of female Patients regarding Oral Contraceptives for Acne Treatment. J Cutan Med Surg, 2001:471-74.

  11. Seaman HE, Vries CS, Farmer RDT. Differences in the use of combined oral contraceptives amongst women with and without acne. Hum Reprod, 2003;18:515 -21.

  12. Krowchuk DP. Treating Acne. Med Clin North Am – Adolescent medicine. 2000:8: 811-24.

  13. Orfanos CE, Zopuboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology.Drugs 1997;53:358–88.

  14. American Academy of Dermatology Consensus Conference on the Safe an Optimal Use of Isotretinoin: Sumary and recommendations. J Am Acad Dermatol 2004;50:900 -6.

  15. De Leo V, La Marca A, Petraglia F. Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome. Endocr Rev, 2003;24:633–67.

  16. Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol, 2002;147:717–25.

  17. Azziz R. The Evaluation and Management of Hirsutism. Obstet Gynecol, 2003;101:995-1007.

  18. Ferriman D, Gallwey JD. Clinical Assessment of body hair growth in women. J Clin Endocrinol Metabol, 1961;21:1440 -47.

  19. Hunter MH, Carek PJ. Evaluation and Treatment of Women with Hirsutism Am Fam Phycisian, 2003;67:2565-72.

  20. Ludwig E. Classification of the types of androgenetic alopecia occuring in the female sex. Br J Dermatol 1977,97:247-54.




2020     |     www.medigraphic.com